• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

CooperVision opens Best Practices 2022 application window

Video

Autumn is in the air—although it doesn’t feel like it at Vision Expo West in Las Vegas—and that means pumpkin spice and application time for CooperVision’s Best Practices program. Michele Andrews, vice president of professional and government affairs, shares details on what’s new with this year’s program.

Transcript

Michele Andrews, OD, FAAO: Hi, everyone, I'm Michele Andrews with CooperVision. I am here at Vision Expo West in Las Vegas and it is time for best practices 2022. This year we are launching our new program, actually our existing program. It is our seventh year with some new changes.


The biggest change for 2022 is that when you apply to be a best practice, you can apply in a category that you are really passionate about, whether that is community service, or innovation, or the patient experience, or team building. Pick one pick many. We just want to hear about you and what you are doing to take care of your patients and build a practice that is thriving. For more information, go to our website, and we look forward to reading your application and celebrating you in 2022.

Related Videos
At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.
Brujic at Rinsada Booth at Vision Expo East 2024
Dr Brianna Rhue, OD, FAAO, FSLS chat about her upcoming presentation at Vision Expo East 2024
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Jeffrey J. Walline, OD, PhD
© 2024 MJH Life Sciences

All rights reserved.